Testing version — LOERadar is in active testing. Features and data may change.
ACTONEL (RISEDRONATE SODIUM) | LOERadar
ACTONEL
NDA
RISEDRONATE SODIUM | N020835 | ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD
5 strengths0 unique patents0 unique exclusivities
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
Para IV certification filed but no ANDA patent litigation cases (NOS 835) matched from PACER. Litigation may be pending or filed under a different caption.
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (5)
Sort:
#001 — 30MG
RLD
0 patents0 exclusivities▴
TABLET;ORAL | Approved: Mar 27, 1998
No patent or exclusivity listings for this strength.
#002 — 5MG
RLD
0 patents0 exclusivities▾
TABLET;ORAL | Approved: Apr 14, 2000
#003 — 35MG
RLDAB
0 patents0 exclusivities▾
TABLET;ORAL | Approved: May 25, 2002
#004 — 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**